Steven Gelone
2020
In 2020, Steven Gelone earned a total compensation of $1.2M as President and Chief Operating Officer at Nabriva Therapeutics AG, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $153,185 |
|---|---|
| Option Awards | $231,493 |
| Salary | $486,300 |
| Stock Awards | $270,863 |
| Other | $12,675 |
| Total | $1,154,516 |
Gelone received $486.3K in salary, accounting for 42% of the total pay in 2020.
Gelone also received $153.2K in non-equity incentive plan, $231.5K in option awards, $270.9K in stock awards and $12.7K in other compensation.
Rankings
In 2020, Steven Gelone's compensation ranked 8,017th out of 13,090 executives tracked by ExecPay. In other words, Gelone earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,017 out of 13,090 | 39th |
Division Manufacturing | 3,399 out of 5,620 | 40th |
Major group Chemicals And Allied Products | 1,375 out of 2,253 | 39th |
Industry group Drugs | 1,197 out of 1,953 | 39th |
Industry Pharmaceutical Preparations | 890 out of 1,458 | 39th |
Source: SEC filing on July 11, 2022.
Gelone's colleagues
We found one more compensation record of an executive who worked with Steven Gelone at Nabriva Therapeutics AG in 2020.
2020
Theodore Schroeder
Nabriva Therapeutics AG